newsfilter
← Latest News
PR Newswire·

REGENXBIO to Host Investor Event Highlighting Surabgene Lomparvovec (Sura-vec) in Wet AMD on October 20

Event to include clinical program overview and perspectives from leading retina specialists ahead of topline pivotal data readout anticipated in 4Q 2026ROCKVILLE, Md., Oct. 12, 2026 /PRNewswire/ -- REGENXBIO Inc.